Image Source: AsiaOne
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023Showcasing full suite of molecular biology workflow solutions for streamlining antibody discoveryGlobeNewswireJune 06, 2023SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody and therapeutics development at Antibody Engineering and Therapeutics, Europe in Amsterdam, The Netherlands. In addition to the exhibition, Jason Lehmann, PhD Senior Product Marketing Manager at Telesis Bio will present “The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking Through Critical Synthesis Bottlenecks” in the opening day session.
Source: AsiaOne